These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren's syndrome. Kudo H, Tsuboi H, Asashima H, Takahashi H, Ono Y, Abe S, Honda F, Kondo Y, Wakasa Y, Takaiwa F, Takano M, Matsui M, Matsumoto I, Sumida T. Mod Rheumatol; 2020 Sep; 30(5):884-893. PubMed ID: 31490711 [Abstract] [Full Text] [Related]
5. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome. Asashima H, Tsuboi H, Takahashi H, Hirota T, Iizuka M, Kondo Y, Matsui M, Matsumoto I, Sumida T. Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013 [Abstract] [Full Text] [Related]
6. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome. Kim JW, Kim SM, Park JS, Hwang SH, Choi J, Jung KA, Ryu JG, Lee SY, Kwok SK, Cho ML, Park SH. Arthritis Res Ther; 2019 Jun 04; 21(1):136. PubMed ID: 31164166 [Abstract] [Full Text] [Related]
7. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. Li X, Li X, Qian L, Wang G, Zhang H, Wang X, Chen K, Zhai Z, Li Q, Wang Y, Harris DC. J Rheumatol; 2007 Dec 04; 34(12):2438-45. PubMed ID: 18050367 [Abstract] [Full Text] [Related]
8. Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome. Gerossier E, Nayar S, Froidevaux S, Smith CG, Runser C, Iannizzotto V, Vezzali E, Pierlot G, Mentzel U, Murphy MJ, Martinic MM, Barone F. Arthritis Res Ther; 2021 Nov 29; 23(1):289. PubMed ID: 34839819 [Abstract] [Full Text] [Related]
9. Reconstruction of Sjögren's syndrome-like sialadenitis by a defined disease specific gut-reactive single TCR and an autoantibody. Iizuka-Koga M, Ito M, Yumoto N, Mise-Omata S, Hayakawa T, Komai K, Chikuma S, Takahashi S, Matsumoto I, Sumida T, Yoshimura A. Clin Immunol; 2024 Jul 29; 264():110258. PubMed ID: 38762063 [Abstract] [Full Text] [Related]
10. P2Y2 receptor antagonism resolves sialadenitis and improves salivary flow in a Sjögren's syndrome mouse model. Jasmer KJ, Woods LT, Forti KM, Martin AL, Camden JM, Colonna M, Weisman GA. Arch Oral Biol; 2021 Apr 29; 124():105067. PubMed ID: 33561807 [Abstract] [Full Text] [Related]
12. Tissue-Resident Memory CD8+ T Cells Acting as Mediators of Salivary Gland Damage in a Murine Model of Sjögren's Syndrome. Gao CY, Yao Y, Li L, Yang SH, Chu H, Tsuneyama K, Li XM, Gershwin ME, Lian ZX. Arthritis Rheumatol; 2019 Jan 29; 71(1):121-132. PubMed ID: 30035379 [Abstract] [Full Text] [Related]
17. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome. Yanagi K, Ishimaru N, Haneji N, Saegusa K, Saito I, Hayashi Y. Eur J Immunol; 1998 Oct 29; 28(10):3336-45. PubMed ID: 9808203 [Abstract] [Full Text] [Related]
18. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. Alunno A, Petrillo MG, Nocentini G, Bistoni O, Bartoloni E, Caterbi S, Bianchini R, Baldini C, Nicoletti I, Riccardi C, Gerli R. Rheumatology (Oxford); 2013 Aug 29; 52(8):1387-96. PubMed ID: 23674818 [Abstract] [Full Text] [Related]